Safety And Efficacy Of Coenzyme Q10 Supplementation In Early Chronic Peyronie's Disease: A Double-blind, Placebo-controlled Randomized Study

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 186
Sex Male
Age Range 18-29, 30-44
Body Types Overweight, Average
Notes for this study:
CoQ10, at 300mg daily for 24 weeks, was able to improve erection quality and reduce pain associated with erections in persons with Peyronie's Disease. CoQ10 was able to reduce disease progression as well as improve penile curvature and plaque in a good deal of the experimental group.